What Does the FDA's BPA Decision Mean for Companies?
Richard Liroff | Greenbiz.com
When the Food and Drug Administration earlier this month expressed for the first time some concern about bisphenol A, it no doubt caused some panic among potentially impacted firms — but it also opened the door of opportunity for early movers.
***
Stephen Whipp and Manulife Securities Incorporated (Manulife) do not make any representation that the information in any linked site is accurate and will not accept any responsibility or liability for any inaccuracies in the information not maintained by them, such as linked sites. Any opinion or advice expressed in a linked site should not be construed as the opinion or advice of Stephen Whipp or Manulife. The information in this communication is subject to change without notice.
Commenting is closed for this article.